Chapters

Transcript

Video

What are the specific patient types that you manage in your lipid-focused practice and which are referred to you for potential intervention with a PCSK9 inhibitor? Why are these patients being referred to you for PCSK9-mediated LDL-C reduction?

What are the specific patient types that you manage in your lipid-focused practice and which are referred to you for potential intervention with a PCSK9 inhibitor? Why are these patients being referred to you for PCSK9-mediated LDL-C reduction?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Anne C. Goldberg, MD, FNLA, FACP, FAHA

Anne C. Goldberg, MD, FNLA, FACP, FAHA

Professor of Medicine
Division of Endocrinology, Metabolism & Lipid Research
Washington University in St. Louis
St. Louis, MO